Healthcare & Life Sciences
Samsara Therapeutics
United Stateswww.samsaratherapeutics.com/
aliveseries-a
series-a
Stage
About
Samsara Therapeutics develops novel therapeutics for neurodegenerative diseases by activating autophagy pathways, targeting conditions such as ALS, Parkinson's Disease, and Charcot-Marie-Tooth disease using patient-derived iPSC screening.
Explore Samsara Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.